Sign in with Google
|
USD 2.42
Price
-0.57
(-19.06%)
Day Change
|
|
|---|
PBYI, the overall quality is good (Quality = 77) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.
In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
67% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 4 |
| Magic Formula Rank by ROA |
158
|
| Magic Formula Rank by ROE |
158
|
| Magic Formula Rank by ROIC |
48
GREAT
|
| Price | 2.42 |
| PBV / Sector |
1.67 / 1.39
|
| Earning Per Share | 0.47 |
| PE / Sector |
5.15 / 17.53
GREAT
|
| PEG or PE/Growth / Sector |
0.03 / 5.75
GREAT
|
| Average 1M Daily Value |
1.54 M
GREAT
|
| Average 1W Daily Value |
3.10 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| Key Statistics |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2024-11-16 19:31:40 |
| Symbol | PBYI |
| Name | PUMA BIOTECHNOLOGY INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 49.09 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 118.79 / 3,831.30 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
UTHR 
